Riassunto: BeOne Medicines annuncia i dati di fase 3 HERIZON-GEA pubblicati in NEJM e presentati all'ASCO 2026
businesswire.com
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in